- Haemonetics 2nd Quarter Fiscal Year 2023 Earnings Release Available on Investor Relations Website
- Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2023 Results: November 7, 2022
- Haemonetics Appoints Roy Galvin as President, Global Plasma and Blood Center
- Haemonetics Earns CE Mark for VASCADE® Vascular Closure Product Portfolio
- Haemonetics Announces Agreement to Offer Enhanced Transfusion Management Software to Epic's Global Network of Hospitals
Haemonetics Corp (HAZ:FRA) closed at 79.50, -7.02% below its 52-week high of 85.50, set on Oct 31, 2022.
38.60Feb 04 202285.50Oct 31 2022
Markit short selling activity
|Market cap||4.23bn USD|
|EPS (TTM)||1.67 |
Data delayed at least 15 minutes, as of Nov 25 2022 08:59 GMT.